Medifast, Inc.
General ticker "MED" information:
- Sector: Consumer Discretionary
- Industry: Personal Products & Services
- Capitalization: $134.7M (TTM average)
Medifast, Inc. follows the US Stock Market performance with the rate: 10.1%.
Estimated limits based on current volatility of 2.8%: low 12.15$, high 12.69$
Factors to consider:
- Total employees count: 380 (-24.6%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Strategic risks and growth management, Market competition, Consumer preference shifts, Coach network retention growth, Product innovation appeal
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [7.18$, 13.55$]
- 2026-12-31 to 2027-12-31 estimated range: [6.39$, 12.22$]
Financial Metrics affecting the MED estimates:
- Negative: with PPE of -17.1 at the end of fiscal year the price was high
- Positive: -4.23 < Operating profit margin, % of -3.55
- Negative: negative Net income
- Positive: 0 < Industry operating cash flow per share per price (median), % of 5.47
- Negative: Investing cash flow per share per price, % of -6.60 <= -4.49
- Positive: Industry inventory ratio change (median), % of -0.55 <= -0.14
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: 0.28 < Operating cash flow per share per price, % of 5.71
- Positive: Inventory ratio change, % of -1.64 <= -0.75
Short-term MED quotes
Long-term MED plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,072.05MM | $602.46MM | $385.79MM |
| Operating Expenses | $945.65MM | $599.59MM | $400.00MM |
| Operating Income | $126.40MM | $2.88MM | $-14.21MM |
| Non-Operating Income | $2.40MM | $0.91MM | $8.57MM |
| Income(Loss) | $128.80MM | $3.79MM | $-5.64MM |
| Taxes | $29.38MM | $1.70MM | $13.03MM |
| Net Income(Loss)* | $99.42MM | $2.09MM | $-18.67MM |
| Stockholders Equity | $201.48MM | $210.11MM | $198.92MM |
| Inventory | $54.59MM | $42.42MM | $20.23MM |
| Assets | $309.91MM | $284.21MM | $247.97MM |
| Operating Cash Flow | $147.66MM | $24.48MM | $6.86MM |
| Capital expenditure | $6.48MM | $7.45MM | $5.61MM |
| Investing Cash Flow | $-61.05MM | $-26.52MM | $-7.93MM |
| Financing Cash Flow | $-79.79MM | $-1.51MM | $-0.56MM |
| Earnings Per Share** | $9.13 | $0.19 | $-1.70 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.